SKNY · LIR Life Sciences Corp. · Insider Trading
Market Cap
4.01M CAD
Shares
28.67M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Transactions in LIR Life Sciences Corp. securities by its insiders (directors, officers and significant shareholders) as filed on SEDI, the Canadian Securities Administrators' insider disclosure system.
Insider transactions
Insider transactions as filed on SEDI, each amended transaction at its newest amendment only. Capture began with about the year before its first read and grows daily, so older history is not included. Amounts are signed (negative for a disposition) and counted in the units of the security named, which may be options, share units or warrants rather than shares. Prices are in the stated currency. Holding after is the insider's balance of that security after the transaction, as filed.
| Transaction date | Insider | Transaction | Security | Amount | Price | Holding after | Filed |
|---|---|---|---|---|---|---|---|
| 2026-10-08 | Dybul, Mark Director of Issuer | Redemption, retraction, cancellation, repurchase | Common Shares | -50,000 | 100,000Direct | 2026-10-09 | |
| 2026-10-04 | Dybul, Mark Director of Issuer | Conversion or exchange | Common Shares | +50,000 | 150,000Direct | 2026-10-04 | |
| 2026-10-04 | Dybul, Mark Director of Issuer | Conversion or exchange | RightsUnderlying: Rights Restricted Share Units | -50,000 | 0Direct | 2026-10-04 | |
| 2026-10-04 | May, Kevin Mitchell Director of Issuer | Conversion or exchange | Common Shares | +50,000 | 150,000Direct | 2026-10-04 | |
| 2026-10-04 | May, Kevin Mitchell Director of Issuer | Conversion or exchange | RightsUnderlying: Rights Restricted Share Units | -50,000 | 0Direct | 2026-10-04 | |
| 2026-10-04 | Carmichel, Constantine Director of Issuer | Conversion or exchange | Common Shares | +50,000 | 50,000Direct | 2026-10-04 | |
| 2026-10-04 | Carmichel, Constantine Director of Issuer | Conversion or exchange | RightsUnderlying: Rights Restricted Share Units | -50,000 | 250,000Direct | 2026-10-04 | |
| 2026-10-04 | Mills, Edward Director of Issuer · Held by MACREVIEWS HEALTH CONSULTING INCORPORATED | Conversion or exchange | Common Shares | +300,000 | 2,702,714Indirect | 2026-10-04 | |
| 2026-10-04 | Mills, Edward Director of Issuer · Held by MACREVIEWS HEALTH CONSULTING INCORPORATED | Conversion or exchange | RightsUnderlying: Rights Restricted Share Units | -300,000 | 0Indirect | 2026-10-04 | |
| 2026-06-04 | Nijjar, Harpreet Senior Officer of Issuer | Grant of rights | RightsUnderlying: Rights Restricted Share Units | +50,000 | 50,000Direct | 2026-06-08 | |
| 2026-06-04 | Dybul, Mark Director of Issuer | Grant of rights | RightsUnderlying: Rights Restricted Share Units | +50,000 | 50,000Direct | 2026-06-08 | |
| 2026-06-04 | May, Kevin Mitchell Director of Issuer | Grant of rights | RightsUnderlying: Rights Restricted Share Units | +50,000 | 50,000Direct | 2026-06-08 | |
| 2026-06-04 | Carmichel, Constantine Director of Issuer | Grant of rights | RightsUnderlying: Rights Restricted Share Units | +50,000 | 300,000Direct | 2026-06-08 | |
| 2026-06-04 | Mills, Edward Director of Issuer · Held by MACREVIEWS HEALTH CONSULTING INCORPORATED | Grant of rights | RightsUnderlying: Rights Restricted Share Units | +300,000 | 300,000Indirect | 2026-06-08 | |
| 2026-04-18 | Dybul, Mark Director of Issuer | Conversion or exchange | Common Shares | +100,000 | 100,000Direct | 2026-04-20 | |
| 2026-04-18 | Dybul, Mark Director of Issuer | Conversion or exchange | RightsUnderlying: Rights Restricted Share Units | -100,000 | 0Direct | 2026-04-20 | |
| 2026-04-18 | May, Kevin Mitchell Director of Issuer | Conversion or exchange | Common Shares | +100,000 | 100,000Direct | 2026-04-20 | |
| 2026-04-18 | May, Kevin Mitchell Director of Issuer | Conversion or exchange | RightsUnderlying: Rights Restricted Share Units | -100,000 | 0Direct | 2026-04-20 | |
| 2026-04-17 | Nijjar, Harpreet Senior Officer of Issuer | Exercise of rights | Common Shares | +100,000 | 100,000Direct | 2026-04-20 | |
| 2025-12-18 | Carmichel, Constantine Director of Issuer | Grant of rights | RightsUnderlying: Rights Restricted Share Units | +250,000 | 250,000Direct | 2025-12-29 | |
| 2025-12-18 | Dybul, Mark Director of Issuer | Grant of rights | RightsUnderlying: Rights Restricted Share Units | +100,000 | 100,000Direct | 2025-12-23 | |
| 2025-12-18 | May, Kevin Mitchell Director of Issuer | Grant of rights | RightsUnderlying: Rights Restricted Share Units | +100,000 | 100,000Direct | 2025-12-23 | |
| 2025-12-15 | Mills, Edward Director of Issuer | Acquisition or disposition in the public market | Common Shares | +10,000 | 1.58 CAD | 155,600Direct | 2025-12-16 |
| 2025-12-11 | Mills, Edward Director of Issuer | Acquisition or disposition in the public market | Common Shares | +3,800 | 145,600Direct | 2025-12-11 | |
| 2025-12-09 | Mills, Edward Director of Issuer | Acquisition or disposition in the public market | Common Shares | +11,000 | 141,800Direct | 2025-12-11 | |
| 2025-12-08 | Mills, Edward Director of Issuer | Acquisition or disposition in the public market | Common Shares | +16,000 | 130,800Direct | 2025-12-09 | |
| 2025-12-05 | Mills, Edward Director of Issuer | Acquisition or disposition in the public market | Common Shares | +19,700 | 114,800Direct | 2025-12-05 | |
| 2025-12-04 | Mills, Edward Director of Issuer | Acquisition or disposition in the public market | Common Shares | +1,800 | 1.02 CAD | 95,100Direct | 2025-12-05 |
| 2025-12-04 | Mills, Edward Director of Issuer · Held by MACREVIEWS HEALTH CONSULTING INCORPORATED | Acquisition or disposition in the public market | Common Shares | +50,000 | 2,402,714Indirect | 2025-12-05 | |
| 2025-12-02 | Mills, Edward Director of Issuer | Acquisition or disposition in the public market | Common Shares | +36,300 | 93,300Direct | 2025-12-02 | |
| 2025-12-01 | Mills, Edward Director of Issuer | Acquisition or disposition in the public market | Common Shares | +57,000 | 0.94 CAD | 57,000Direct | 2025-12-01 |
| 2025-11-04 | Carmichel, Constantine Director of Issuer | Opening Balance-Initial SEDI Report | Common Shares | 0 | Direct | 2026-10-04 | |
| 2025-11-04 | Nijjar, Harpreet Senior Officer of Issuer | Opening Balance-Initial SEDI Report | RightsUnderlying: Rights Restricted Share Units | 0 | Direct | 2026-06-08 | |
| 2025-11-04 | Mills, Edward Director of Issuer · Held by MACREVIEWS HEALTH CONSULTING INCORPORATED | Opening Balance-Initial SEDI Report | RightsUnderlying: Rights Restricted Share Units | 0 | Indirect | 2026-06-08 | |
| 2025-11-04 | Nijjar, Harpreet Senior Officer of Issuer | Opening Balance-Initial SEDI Report | Common Shares | 0 | Direct | 2026-04-20 | |
| 2025-11-04 | Carmichel, Constantine Director of Issuer | Opening Balance-Initial SEDI Report | RightsUnderlying: Rights Restricted Share Units | 0 | Direct | 2025-12-29 | |
| 2025-11-04 | Dybul, Mark Director of Issuer | Opening Balance-Initial SEDI Report | RightsUnderlying: Rights Restricted Share Units | 0 | Direct | 2025-12-23 | |
| 2025-11-04 | May, Kevin Mitchell Director of Issuer | Opening Balance-Initial SEDI Report | RightsUnderlying: Rights Restricted Share Units | 0 | Direct | 2025-12-23 | |
| 2025-11-04 | Mills, Edward Director of Issuer | Opening Balance-Initial SEDI Report | Common Shares | 0 | Direct | 2025-12-01 | |
| 2025-11-04 | Mills, Edward Director of Issuer | Opening Balance-Initial SEDI Report | WarrantsUnderlying: Common Shares | 0 | Direct | 2025-11-04 | |
| 2025-11-04 | Mills, Edward Director of Issuer | Opening Balance-Initial SEDI Report | OptionsUnderlying: Common Shares | 0 | Direct | 2025-11-04 | |
| 2025-11-04 | Dybul, Mark Director of Issuer | Opening Balance-Initial SEDI Report | WarrantsUnderlying: Common Shares | 0 | Direct | 2025-11-04 | |
| 2025-11-04 | Dybul, Mark Director of Issuer | Opening Balance-Initial SEDI Report | OptionsUnderlying: Common Shares | 0 | Direct | 2025-11-04 | |
| 2025-11-04 | Dybul, Mark Director of Issuer | Opening Balance-Initial SEDI Report | Common Shares | 0 | Direct | 2025-11-04 | |
| 2025-11-04 | May, Kevin Mitchell Director of Issuer | Opening Balance-Initial SEDI Report | WarrantsUnderlying: Common Shares | 0 | Direct | 2025-11-04 | |
| 2025-11-04 | May, Kevin Mitchell Director of Issuer | Opening Balance-Initial SEDI Report | OptionsUnderlying: Common Shares | 0 | Direct | 2025-11-04 | |
| 2025-11-04 | May, Kevin Mitchell Director of Issuer | Opening Balance-Initial SEDI Report | Common Shares | 0 | Direct | 2025-11-04 | |
| 2025-11-04 | Mills, Edward Director of Issuer · Held by MACREVIEWS HEALTH CONSULTING INCORPORATED | Opening Balance-Initial SEDI Report | Common Shares | 0 | 2,352,714Indirect | 2025-11-04 | |
| 2025-11-03 | Verbaas, Jacob (Jaap) Senior Officer of Issuer | Stock split or consolidation | OptionsUnderlying: Common Shares | -250,000 | 500,000Direct | 2025-11-03 | |
| 2025-11-03 | Verbaas, Jacob (Jaap) Senior Officer of Issuer · Held by 1222208 BC Ltd. | Stock split or consolidation | Common Shares | -316,667 | 633,333Indirect | 2025-11-03 |
54 transactions between 2025-11-03 and 2026-10-08. Checked 2026-11-08 17:01 UTC.
Showing 1–50 of 54 transactions